# Zhongguancun Collaborative Innovation Fund

> Zhongguancun Collaborative Innovation Fund is a VC fund backing Biotechnology. See 10 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 10
- Last investment: Mar 2026
- Lead investor: 40%
- Last updated: Aug 2026
- Website: http://www.zgcco-innovationfund.com.cn

Zhongguancun Collaborative Innovation Fund is a VC fund focused on Biotechnology and Health Care. Zhongguancun Collaborative Innovation Fund employs market-oriented mechanism operation and management.

## Contacts

5 contacts available for Zhongguancun Collaborative Innovation Fund. Shizune tracks 1 team members at Zhongguancun Collaborative Innovation Fund. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/zhongguancun-collaborative-innovation-fund?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 40% |
| Health Care | 3 | 30% |
| Manufacturing | 2 | 20% |
| Health Diagnostics | 2 | 20% |
| AgTech | 1 | 10% |

25 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 4 | 40% |
| Angel | 2 | 20% |
| Series B | 2 | 20% |
| Series A | 1 | 10% |
| Series C | 1 | 10% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Sun Cisuo | managing partner | 6 | https://shizune.co/investors/profile/sun-cisuo |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Xiaocheng Changnu | Xiaocheng Changnu is an elderly care service operator. | $14.5M | Series B | Mar 30, 2026 |  |
| Taihao Biotechnology | Taihao Biotechnology specializes in research, development, production, and sales of rapid testing equipment for biomolecular detection. |  | Seed | Jul 22, 2025 |  |
| Zhuoshi Technology | Zhuoshi Future is an education platform that builds core technical barriers, creates a powerful product platform, and provides customers with full-link, full-scenario, and full-cycle metaverse solutions. They covered education, cultural tourism, publishing, broadcasting, and corporate governments. |  | Series B | Jan 05, 2024 |  |
| Chixin Microelectronics | Chixin Microelectronics is a supplier of silicon carbide plastic power module testing and packaging services. It is committed to creating new technologies for power module packaging and testing. |  | Seed | Nov 14, 2023 |  |
| Migrasome Therapeutics | Migrasome Therapeutics is an innovative drug research and development company based on new biological discoveries. | $14M | Angel | Jul 26, 2023 |  |
| Link Touch | Link Touch specializes in the research, development, and production of force sensors and force control products. It has deep experience accumulation and technical advantages in multi-dimensional force sensors, joint torque sensors, and robot force control technology. |  | Seed | Jun 27, 2023 |  |
| Automotive Walking Technology | Automotive Walking Technology is a manufacturing company that develops automated robotics to work on rubber farms for the tapping process. |  | Angel | Jan 17, 2023 |  |
| Toll PATEO | Toll PATEO is a natural science, medical research and experimental development service provider. | $15.8M | Series A | Mar 09, 2022 |  |
| Qinghui Liannuo | Qinghui Liannuo is a scientific and technological innovation enterprise that transforms Tsinghua University's achievements in the research and development and application of immunotherapy technology. Actively promote the development of the γδ-T cell immunotherapy industry. Committed to bringing good news to patients with refractory andrecurrent solid tumors and hematomas. | $15.7M | Seed | Nov 22, 2021 |  |
| GenomePrecision | Genomeprecision is a molecular diagnostic enterprise integrating R&D, production and sales. It has established “real-time fluorescent quantitative PCR”, “first-generation Sanger sequencing”, “second-generation high-throughput NGS sequencing” and “capillary electrophoresis”. "Fragment Analysis" and "Chemiluminescence CLIA"five molecular diagnostic technology platforms, we will be based on clinical diagnosis and treatment needs to develop molecular diagnostic products based on the above technology platform. | $30.7M | Series C | Apr 19, 2021 |  |

10 of 10 investments shown.

## Co-investors
- [Longpan Investment](https://shizune.co/investors/profile/longpan-investment) — VC Fund, 2 deals together
- [ZGC Group](https://shizune.co/investors/profile/zgc-group) — VC Fund, 2 deals together
- [ZGC Group](https://shizune.co/investors/profile/zhongguancun-qihang-vc) — VC Fund, 2 deals together
- [Addor Capital](https://shizune.co/investors/profile/addor-capital) — VC Fund, 1 deal together
- [Beijing Capital Science and Technology Development Group](https://shizune.co/investors/profile/beijing-capital-science-and-technology-development-group) — VC Fund, 1 deal together
- [CAS Star](https://shizune.co/investors/profile/cas-star) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Life Science Investors in China](https://shizune.co/investors/life-science-investors-china)
- [Life Science VC Funds in China](https://shizune.co/investors/life-science-vc-funds-china)
- [Life Science VC Funds in Asia](https://shizune.co/investors/life-science-vc-funds-asia)

## FAQ

### What does Zhongguancun Collaborative Innovation Fund invest in?

Zhongguancun Collaborative Innovation Fund invests primarily in Biotechnology, Health Care and Manufacturing startups, most often at Seed and Angel stage. Most of the 10 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Zhongguancun Collaborative Innovation Fund?

Public channels for Zhongguancun Collaborative Innovation Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Zhongguancun Collaborative Innovation Fund?

The team at Zhongguancun Collaborative Innovation Fund includes Sun Cisuo (managing partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co